Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Chimeric and humanized antibodies with specificity for the CD33 antigenM S Co, N M Avdalovic, P C Caron, et al.The Journal of Experimental Medicine|October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodiesP C Caron, W Laird, M S Co, et al.Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.Molecular Immunology|October 1, 1993
Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyM S Co, D A Scheinberg, N M Avdalovic, et al.Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.Current Opinion in Oncology|January 1, 1994
Immunotherapy for acute leukemiasP C Caron, D A ScheinbergLeukemia & Lymphoma|January 1, 1993
Anti-CD33 monoclonal antibody M195 for the therapy of myeloid leukemiaP C Caron, D A ScheinbergCancer Investigation|January 1, 1997
The biological therapy of acute and chronic leukemiaP C Caron, D A ScheinbergClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemiaP C Caron, L Dumont, D A ScheinbergPageof 17